Submitted by Anonymous (not verified) on 23 July 2025 - 9:40
Human medicines European public assessment report (EPAR): Rivaroxaban Viatris (previously Rivaroxaban Mylan), rivaroxaban, Date of authorisation: 12/11/2021, Revision: 9, Status: Authorised
Source: